We’re thrilled to have been appointed to handle a European PR and stakeholder engagement programme for Amsterdam based EATRIS (the European Infrastructure for Translational Medicine).
The agency has been engaged to build advocacy and awareness for EATRIS’s strategy of taking biomedical innovations ‘from bench to bedside’ working with over 70 leading academic institutions across Europe.
Frank de Man, Finance Director of EATRIS, said; “We operate in a complex environment and Rule 5 demonstrated that they understand that. We were impressed with their credentials and are working with them to build sustainable relationships with key journalists and stakeholders.”
It’s an important win for the agency and is our first client located outside the UK. Work is already underway with the team conducting highly targeted media relations activity and informing the European science and medical communities about the links to world-leading facilities the organisation provides.
EATRIS is a new organisation providing a development pathway in the progression of biomedical innovations. EATRIS provides researchers, SMEs and medical companies with a single point of access to the expertise, facilities and clinical patient cohorts, expediting the treatment development process.